Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17180.18 158.33 NIFTY 5103.55 51.10
 

AstraZeneca Pharma Key Financial Ratios, AstraZeneca Pharma Financial Statement & Accounts

AstraZeneca Pharma

BSE: 506820  |  NSE: ASTRAZEN  |  ISIN: INE203A01020  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Key Financial Ratios of AstraZeneca Pharma

------------------- in Rs. Cr. -------------------
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
Investment Valuation Ratios
Face Value 10.00 10.00 2.00 2.00 2.00
Dividend Per Share 50.00 20.00 12.00 15.00 15.00
Operating Profit Per Share (Rs) 97.11 125.79 29.50 36.77 45.64
Net Operating Profit Per Share (Rs) 384.57 451.30 107.52 121.23 142.53
Free Reserves Per Share (Rs) 181.08 244.39 54.69 61.72 31.96
Bonus in Equity Capital 50.00 50.00 50.00 50.00 50.00
Profitability Ratios
Operating Profit Margin(%) 25.25 27.87 -- -- 32.02
Profit Before Interest And Tax Margin(%) 22.60 25.05 -- -- 29.21
Gross Profit Margin(%) 26.38 29.30 -- -- 30.09
Cash Profit Margin(%) 15.44 20.95 -- -- 21.62
Adjusted Cash Margin(%) 17.20 19.87 19.81 21.49 21.62
Net Profit Margin(%) 13.18 18.69 17.66 19.68 20.11
Adjusted Net Profit Margin(%) 14.93 17.62 -- -- 20.11
Return On Capital Employed(%) 49.34 49.02 -- -- 65.98
Return On Net Worth(%) 26.95 33.85 34.39 -- 63.56
Adjusted Return on Net Worth(%) 30.53 31.90 34.52 38.45 62.40
Return on Assets Excluding Revaluations 15.38 24.08 20.05 24.64 25.39
Return on Assets Including Revaluations 15.38 24.08 20.05 24.64 25.39
Return on Long Term Funds(%) 49.34 49.02 53.02 59.72 65.98
Liquidity And Solvency Ratios
Current Ratio 1.92 2.86 2.07 2.40 2.32
Quick Ratio 1.50 2.28 1.69 2.08 1.97
Debt Equity Ratio -- -- -- -- 0.54
Long Term Debt Equity Ratio -- -- -- -- 0.54
Debt Coverage Ratios
Interest Cover 1,469.23 1,144.30 -- -- 24.24
Total Debt to Owners Fund -- -- -- -- 0.54
Financial Charges Coverage Ratio 1,606.84 1,239.62 -- -- 25.65
Financial Charges Coverage Ratio Post Tax 941.10 886.43 -- -- 17.60
Management Efficiency Ratios
Inventory Turnover Ratio 7.59 9.17 8.11 -- 11.79
Debtors Turnover Ratio 9.47 8.82 7.11 6.61 7.33
Investments Turnover Ratio 8.88 10.82 9.14 15.11 11.79
Fixed Assets Turnover Ratio 6.93 7.46 8.34 -- 4.40
Total Assets Turnover Ratio 2.01 1.77 -- -- 1.99
Asset Turnover Ratio 2.91 3.10 3.52 3.66 4.40
Average Raw Material Holding 68.27 67.57 59.32 46.54 57.65
Average Finished Goods Held 36.83 33.20 46.98 27.15 34.48
Number of Days In Working Capital 123.90 153.11 145.23 149.75 149.72
Profit & Loss Account Ratios
Material Cost Composition 29.02 33.69 38.23 28.81 31.10
Imported Composition of Raw Materials Consumed 19.49 32.79 32.35 31.84 30.91
Selling Distribution Cost Composition 5.78 5.64 5.27 6.51 6.24
Expenses as Composition of Total Sales 1.87 1.65 2.32 2.91 6.76
Cash Flow Indicator Ratios
Dividend Payout Ratio Net Profit 109.77 26.48 70.18 71.38 59.42
Dividend Payout Ratio Cash Profit 93.70 23.63 62.80 65.19 54.35
Earning Retention Ratio 3.11 71.91 30.10 28.39 39.47
Cash Earning Retention Ratio 15.85 75.10 37.43 34.62 44.72
AdjustedCash Flow Times -- -- -- -- 0.79
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
Earnings Per Share 51.50 86.12 19.49 24.58 29.53
Book Value 191.08 254.39 56.69 63.72 46.46
Source : Religare Technova
Explore AstraZeneca connections